{
    "id": "dbpedia_6075_2",
    "rank": 64,
    "data": {
        "url": "https://www.ed.ac.uk/profile/david-cameron",
        "read_more_link": "",
        "language": "en",
        "title": "David Cameron",
        "top_image": "https://www.ed.ac.uk/sites/all/themes/uoe/assets/uoe-logo-centred-black.png",
        "meta_img": "https://www.ed.ac.uk/sites/all/themes/uoe/assets/uoe-logo-centred-black.png",
        "images": [
            "https://www.ed.ac.uk/sites/all/themes/uoe/assets/logo.png",
            "https://www.ed.ac.uk/sites/default/files/styles/uoe_profile_picture/public/d.cameron.jpg?itok=9Osiy9EF",
            "https://www.ed.ac.uk/sites/all/themes/uoe/assets/footer-affiliations.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2024-06-19T00:00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://www.ed.ac.uk/sites/all/themes/uoe/favicon/favicon-32x32.png?t=shw8z1",
        "meta_site_name": "The University of Edinburgh",
        "canonical_link": "https://www.ed.ac.uk/profile/david-cameron",
        "text": "Background\n\nDavid Cameron is currently Professor of Oncology at Edinburgh University, and works in NHS Lothian’s cancer centre treating breast cancer patients, and is currently also the part/time deputy director role within the Scottish Government funded Innovative Health Care Delivery Programme (IHDP) which seeks to improve on access to, and enhance the use of, routine data on cancer patients within NHS Scotland. He also chairs the Scottish National SACT programme board and Cancer SACT data group.\n\nInternationally he is the chair of the Breast International Group Executive Board, a Brussels-based umbrella group of 57 worldwide academic/not-for-profit breast cancer trials’ groups, and the vice chair of the steering group of the Oxford-based Early Breast Cancer Clinical Trialists’ Group. He is active in a number of current and past national and international clinical trials in breast cancer."
    }
}